Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Venlafaxine 150mg modified-release capsules
0403040W0AAAEAE
|
Venlafaxine | Venlafaxine | Central Nervous System | 173,142 |
|
Venlafaxine 75mg modified-release capsules
0403040W0AAADAD
|
Venlafaxine | Venlafaxine | Central Nervous System | 160,647 |
|
Venlafaxine 75mg tablets
0403040W0AAABAB
|
Venlafaxine | Venlafaxine | Central Nervous System | 110,402 |
|
Venlafaxine 37.5mg tablets
0403040W0AAAAAA
|
Venlafaxine | Venlafaxine | Central Nervous System | 102,150 |
|
Venlafaxine 150mg modified-release tablets
0403040W0AAAKAK
|
Venlafaxine | Venlafaxine | Central Nervous System | 90,511 |
|
Venlafaxine 75mg modified-release tablets
0403040W0AAAJAJ
|
Venlafaxine | Venlafaxine | Central Nervous System | 75,684 |
|
Venlafaxine 37.5mg modified-release capsules
0403040W0AAASAS
|
Venlafaxine | Venlafaxine | Central Nervous System | 56,133 |
|
Venlafaxine 225mg modified-release tablets
0403040W0AAALAL
|
Venlafaxine | Venlafaxine | Central Nervous System | 48,279 |
|
Venlafaxine 225mg modified-release capsules
0403040W0AAATAT
|
Venlafaxine | Venlafaxine | Central Nervous System | 43,772 |
|
Venlafaxine 37.5mg modified-release tablets
0403040W0AAAMAM
|
Venlafaxine | Venlafaxine | Central Nervous System | 28,015 |
|
Venlafaxine 300mg modified-release tablets
0403040W0AAAVAV
|
Venlafaxine | Venlafaxine | Central Nervous System | 13,466 |
|
Venlafaxine 75mg/5ml oral solution sugar free
0403040W0AAAXAX
|
Venlafaxine | Venlafaxine | Central Nervous System | 644 |
|
Venlafaxine 37.5mg/5ml oral solution sugar free
0403040W0AAAWAW
|
Venlafaxine | Venlafaxine | Central Nervous System | 334 |
|
Venlafaxine 75mg/5ml oral solution
0403040W0AAAQAQ
|
Venlafaxine | Venlafaxine | Central Nervous System | 157 |
|
Venlafaxine 75mg/5ml oral suspension
0403040W0AAARAR
|
Venlafaxine | Venlafaxine | Central Nervous System | 56 |
|
Venlafaxine 37.5mg/5ml oral solution
0403040W0AAANAN
|
Venlafaxine | Venlafaxine | Central Nervous System | 30 |
|
Venlafaxine 37.5mg/5ml oral suspension
0403040W0AAAPAP
|
Venlafaxine | Venlafaxine | Central Nervous System | 20 |
|
Venlafaxine 150mg oral powder sachets
0403040W0AAAHAH
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 150mg/5ml oral liquid
0403040W0AAAIAI
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 225mg/5ml oral suspension
0403040W0AAAUAU
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
|
Venlafaxine 50mg tablets
0403040W0AAACAC
|
Venlafaxine | Venlafaxine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.